Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 2Thoracic 1

Conditions

Carcinoma, Non-Small-Cell Lung 59Small Cell Lung Carcinoma 13Lung Neoplasms 13Colorectal Neoplasms 6Sarcoma 5Neoplasm Metastasis 5Melanoma 5Adenocarcinoma of Lung 4Stomach Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3NSCLC 3Carcinoma, Renal Cell 3Uterine Cervical Neoplasms 2Mesothelioma 2Extensive Stage Small Cell Lung Cancer 2Carcinoma, Hepatocellular 2Anus Neoplasms 2Uveal Melanoma 1Unresectable Stage III Non-small Cell Lung Cancer 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thyroid Carcinoma, Anaplastic 1Testicular Germ Cell Tumor 1Small Cell Lung Cancer Extensive Stage 1SCLC, Extensive Stage 1Radiation Pneumonitis 1Perioperative Immunotherapy 1Pancreatic Neoplasms 1Non-Small Cell Lung Cancer Without Mutation in Epidermal Growth Factor Receptor (Disorder) 1Non Squamous Non-small Cell Lung Cancer 1

Interventions

Radiosurgery 27Radiotherapy 17Magnetic Resonance Spectroscopy 14Erlotinib Hydrochloride 14Bevacizumab 13Pemetrexed 10Carboplatin 10pembrolizumab 9Gefitinib 9osimertinib 8icotinib 7Temozolomide 7Nivolumab 6Specimen Handling 5Paclitaxel 5Spermine Synthase 4Mental Status and Dementia Tests 4Ipilimumab 4Drug Therapy 4Cisplatin 4atezolizumab 3alectinib 3aflutinib 3Radiation 3Immunotherapy 3Fluorodeoxyglucose F18 3regorafenib 2paclitaxel-Angiopep-2 conjugate 2motexafin gadolinium 2epothilone B 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Brain Neoplasms × tislelizumab × Thoracic × Clear all
NCT04507217 2023-05-25

Tislelizumab Combined With Pemetrexed/ Carboplatin in Patients With Brain Metastases of Non-squamous NSCLC

Sun Yat-sen University

Phase 2 Completed
36 enrolled
CNSThoracic

Brain Neoplasms, Carcinoma, Non-Small-Cell Lung

Data powered by HemOnc (CC BY 4.0) Colophon âš¡